GERN Geron Corporation Stock Quote

GERN [NASD]

Index	-	P/E	-	EPS (ttm)	-0.35	Insider Own	0.16%	Shs Outstand	318.80M	Perf Week	2.06%
Market Cap	551.82M	Forward P/E	-	EPS next Y	-0.30	Insider Trans	3.47%	Shs Float	296.50M	Perf Month	4.22%
Income	-80.90M	PEG	-	EPS next Q	-0.07	Inst Own	56.40%	Short Float	18.63%	Perf Quarter	-5.46%
Sales	0.40M	P/S	1379.55	EPS this Y	-135.50%	Inst Trans	1.06%	Short Ratio	23.16	Perf Half Y	-8.47%
Book/sh	0.73	P/B	2.37	EPS next Y	-11.10%	ROA	-37.20%	Target Price	-	Perf Year	23.57%
Cash/sh	0.71	P/C	2.42	EPS next 5Y	5.00%	ROE	-43.80%	52W Range	0.75 - 2.40	Perf YTD	8.81%
Dividend	-	P/FCF	-	EPS past 5Y	-9.20%	ROI	-53.60%	52W High	-27.92%	Beta	1.33
Dividend %	-	Quick Ratio	9.60	Sales past 5Y	-16.80%	Gross Margin	-	52W Low	130.67%	ATR	0.08
Employees	45	Current Ratio	9.60	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	53.48	Volatility	6.18% 5.10%
Optionable	Yes	Debt/Eq	0.10	EPS Q/Q	23.20%	Profit Margin	-	Rel Volume	0.87	Prev Close	1.67
Shortable	Yes	LT Debt/Eq	0.10	Earnings	Nov 05 AMC	Payout	-	Avg Volume	2.38M	Price	1.73
Recom	1.70	SMA20	5.25%	SMA50	-0.91%	SMA200	-0.14%	Volume	2,081,345	Change	3.59%

Aug-03-20

Initiated

Stifel

Buy

Nov-19-19

Resumed

B. Riley FBR

Buy

Sep-03-19

Initiated

H.C. Wainwright

Buy

Aug-15-19

Initiated

Cantor Fitzgerald

Overweight

Apr-09-19

Upgrade

Needham

Hold → Buy

Jan-31-19

Upgrade

B. Riley FBR

Neutral → Buy

$1.50 → $3.25

Oct-02-18

Downgrade

B. Riley FBR

Buy → Neutral

$5.75 → $1.50

Jul-05-18

Initiated

B. Riley FBR, Inc.

Buy

$5.75

Sep-13-16

Reiterated

FBR Capital

Outperform

$6 → $5

Sep-13-16

Reiterated

FBR & Co.

Outperform

$6 → $5

Dec-07-15

Reiterated

Piper Jaffray

Overweight

$5 → $10

Apr-21-15

Initiated

Oppenheimer

Outperform

$5.50

Jun-12-14

Upgrade

MLV & Co

Hold → Buy

$2 → $4.25

Mar-12-14

Downgrade

MLV & Co

Buy → Hold

$9 → $2

Dec-10-13

Upgrade

Needham

Hold → Buy

$10

Dec-10-13

Reiterated

MLV & Co

Buy

$8 → $9

Nov-08-13

Reiterated

MLV & Co

Buy

$6.50 → $8

Oct-16-13

Initiated

MLV & Co

Buy

$6.50

Aug-30-12

Initiated

Stifel Nicolaus

Buy

Jun-28-12

Initiated

Needham

Hold

Jan-21-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jan-14-21 04:45PM	Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference Business Wire
Dec-17-20 01:25PM	Is GERN A Good Stock To Buy Now? Insider Monkey
Dec-11-20 08:30AM	Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business Wire
Dec-10-20 08:30AM	Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS Business Wire
Dec-07-20 06:45PM	Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting Business Wire
Nov-19-20 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Nov-10-20 04:30PM	Geron to Present at the Stifel Virtual Healthcare Conference Business Wire
Nov-08-20 07:51AM	Time To Worry? Analysts Just Downgraded Their Geron Corporation (NASDAQ:GERN) Outlook Simply Wall St.
Nov-06-20 10:31AM	Geron (GERN) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 07:20PM	Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:25PM	Recap: Geron Q3 Earnings Benzinga
04:05PM	Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events GlobeNewswire
Nov-04-20 04:27PM	Geron Announces Ten Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting Business Wire
Nov-02-20 11:58AM	Qorvo, Nikola, BMY, MyoKardia and Geron as Zacks Bull and Bear of the Day Zacks
Oct-29-20 04:30PM	Geron to Announce Third Quarter Financial Results on November 5, 2020 Business Wire
Oct-28-20 04:35PM	Geron Announces Publication of IMerge Phase 2 Data in Journal of Clinical Oncology Business Wire
12:32PM	Geron (GERN) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-23-20 09:03AM	Is Geron Corporation (NASDAQ:GERN) Popular Amongst Institutions? Simply Wall St.
Oct-01-20 04:30PM	Geron Secures Loan Facility for Up to $75 Million Business Wire
Sep-21-20 08:53AM	Geron (GERN) Looks Good: Stock Adds 6.5% in Session Zacks
Sep-17-20 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Sep-09-20 09:00AM	Geron to Present at the H.C. Wainwright Global Investment Conference Business Wire
Aug-24-20 10:52AM	How Should Investors Feel About Geron's (NASDAQ:GERN) CEO Remuneration? Simply Wall St.
Aug-20-20 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Aug-06-20 04:05PM	Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events Business Wire
Aug-04-20 04:45PM	Geron to Present at the BTIG Virtual Biotechnology Conference Business Wire
Jul-30-20 04:30PM	Geron to Announce Second Quarter Financial Results on August 6, 2020 Business Wire
12:33PM	Will Geron (GERN) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-27-20 08:28AM	Geron Sees Hammer Chart Pattern: Time to Buy? Zacks
08:18AM	Geron Sees Hammer Chart Pattern: Time to Buy? Zacks
Jul-23-20 11:30AM	Is Geron (GERN) Stock Outpacing Its Medical Peers This Year? Zacks
Jul-16-20 08:30AM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jul-01-20 08:30AM	Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug Designation in the European Union for Imetelstat to Treat Myelodysplastic Syndromes GlobeNewswire
Jun-30-20 08:01AM	Edited Transcript of GERN earnings conference call or presentation 28-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-25-20 10:36AM	Zealand Announces Dosing Initiation in Type 2 Diabetes Study Zacks
08:38AM	Geron's Shares March Higher, Can It Continue? Zacks
Jun-24-20 12:35PM	Brokers Are Upgrading Their Views On Geron Corporation (NASDAQ:GERN) With These New Forecasts Simply Wall St.
11:30AM	Is Geron (GERN) Stock Outpacing Its Medical Peers This Year? Zacks
Jun-22-20 11:28AM	Dynavax's Partner Doses First Patient in Coronavirus Study Zacks
Jun-19-20 08:50AM	Implied Volatility Surging for Geron Corporation (GERN) Stock Options Zacks
Jun-12-20 08:30AM	Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Association (EHA) Annual Congress GlobeNewswire
Jun-11-20 09:04AM	Moving Average Crossover Alert: Geron Zacks -8.84%
Jun-10-20 09:30AM	Dynavax Closes Enrollment in Renal Disease Study on Heplisav-B Zacks +7.10%
Jun-09-20 09:44AM	Top Ranked Momentum Stocks to Buy for June 9th Zacks
08:40AM	How Geron Corporation (GERN) Stock Stands Out in a Strong Industry Zacks
Jun-05-20 11:30AM	Is Geron (GERN) Outperforming Other Medical Stocks This Year? Zacks
07:29AM	Top Ranked Momentum Stocks to Buy for June 5th Zacks
Jun-02-20 09:08AM	Top Ranked Momentum Stocks to Buy for June 2nd Zacks
May-29-20 05:00PM	Geron Corporation (Delaware) (GERN) Q1 2020 Earnings Call Transcript Motley Fool
May-28-20 06:25PM	Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:05PM	Geron Corporation Reports First Quarter 2020 Financial Results GlobeNewswire
May-27-20 04:30PM	Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants GlobeNewswire
May-22-20 11:11AM	P/E Ratio Insights for Geron Benzinga -6.12%
08:13AM	Geron's stock tumbles after large share offering prices at 34% discount MarketWatch
07:15AM	Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants GlobeNewswire
May-21-20 04:03PM	Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
04:01PM	Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates GlobeNewswire
08:30AM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
May-15-20 01:24PM	Why Geron Stock Soared 23.4% Today Motley Fool +24.11%
May-14-20 02:22PM	3 Strong Buy Penny Stocks With Triple-Digit Upside TipRanks +6.82%
09:05AM	Geron Announces Four Imetelstat Presentations at the Virtual Edition of the European Hematology Association Annual Congress Business Wire
Apr-30-20 12:33PM	Earnings Preview: Geron (GERN) Q1 Earnings Expected to Decline Zacks
Apr-16-20 08:30AM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Apr-09-20 06:08PM	Clinical trials in the age of COVID: Shelter-in-place, hospital restrictions cause drug study delays American City Business Journals
Apr-08-20 04:30PM	Geron to Present at Needham Virtual Healthcare Conference GlobeNewswire
08:46AM	Here's Why We're Not Too Worried About Geron's (NASDAQ:GERN) Cash Burn Situation Simply Wall St.
Apr-04-20 09:25AM	Edited Transcript of GERN earnings conference call or presentation 12-Mar-20 8:30pm GMT Thomson Reuters StreetEvents
Apr-02-20 08:00AM	Geron Provides COVID-19 Related Business Update GlobeNewswire
Mar-23-20 02:15PM	CLASS ACTION UPDATE for GERN, HPQ and CAN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:30PM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:45AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of QD, GERN and AAN ACCESSWIRE
10:40AM	MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Geron Corporation and Encourages Investors with Losses to Contact the Firm Business Wire
10:14AM	GERN FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm ACCESSWIRE
07:00AM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application Deadline Today, Investors with Losses Should Contact Firm Immediately ACCESSWIRE
02:00AM	FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Mar-22-20 12:53PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application Deadline Tomorrow, Investors with Losses Encouraged to Contact Firm ACCESSWIRE
11:05AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GERN, CCI and TLRY ACCESSWIRE
Mar-21-20 03:50PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 2 Days to Application Deadline, Investors with Losses Encouraged to Contact Firm ACCESSWIRE
08:03AM	FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Mar-20-20 05:14PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: Application Deadline 3 Days Away, Investors with Losses Encouraged to Contact Firm GlobeNewswire +6.80%
01:45PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, ALGN and CRON ACCESSWIRE
01:05PM	3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:30AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GERN, WWE and CRON ACCESSWIRE
10:13AM	GERN UPCOMING DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm ACCESSWIRE
09:00AM	GERN Shareholders: March 23, 2020 Filing Deadline in Class Action - Contact Lieff Cabraser ACCESSWIRE
Mar-19-20 08:50PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 4 Days Until Application Deadline, Investors with Losses Encouraged to Contact Firm ACCESSWIRE +16.08%
04:55PM	CLASS ACTION UPDATE for GERN, AAN and MGPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
12:45PM	4-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:30PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GERN, JELD and CRON ACCESSWIRE
11:00AM	GERN FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm Business Wire
10:45AM	SHAREHOLDER ALERT: GERN LK BDX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:20AM	MARCH 23 DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Mar-18-20 08:05PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 5 Days Until Application Deadline, Investors with Losses Encouraged to Contact Firm ACCESSWIRE -6.67%
11:25AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GERN, HPQ and CAN ACCESSWIRE
11:20AM	5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Geron Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:12AM	GERN UPCOMING DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Geron Corporation Investors of Class Action and Encourages Investors to Contact the Firm ACCESSWIRE
Mar-17-20 08:55PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OPRA, GERN and INO ACCESSWIRE +6.82%
08:17PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Geron Corporation (GERN) Investors: 6 Days Until Application Deadline, Investors with Losses Encouraged to Contact Firm ACCESSWIRE
02:45PM	SHAREHOLDER ALERT: GERN TVTY CRON: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It holds rights to imetelstat, a telomerase inhibitor in Phase 2/3 clinical trials, which inhibits the uncontrolled proliferation of malignant progenitor cells in hematologic myeloid malignancies to reduce dysfunctional blood cell production and enable recovery of normal blood cell production. The company was founded in 1990 and is headquartered in Menlo Park, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
O'Farrell Elizabeth G.	Director	Aug 21	Buy	1.73	17,441	30,173	19,641	Aug 24 08:57 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience